XML 74 R51.htm IDEA: XBRL DOCUMENT v3.3.1.900
Acquisitions, Divestitures, Research Collaborations and License Agreements - Pro Forma Financial Information (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Business Combinations [Abstract]    
Sales $ 39,584 $ 43,437
Net income attributable to Merck & Co., Inc. $ 4,640 $ 10,887
Basic earnings per common share attributable to Merck & Co., Inc. common shareholders (in dollars per share) $ 1.65 $ 3.76
Earnings per common share assuming dilution attributable to Merck & Co. Inc. common shareholders (in dollars per share) $ 1.63 $ 3.72